Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-03-10 @ 8:37 PM
Study NCT ID:
NCT01479868
Status:
COMPLETED
Last Update Posted:
2014-10-29
First Post:
2011-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Sponsor:
Janssen R&D Ireland
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR018334
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None